Logo image of CTEK.CA

CLEANTEK INDUSTRIES INC (CTEK.CA) Stock Fundamental Analysis

Canada - TSX-V:CTEK - CA75101V1013 - Common Stock

0.475 CAD
+0.02 (+5.56%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, CTEK scores 3 out of 10 in our fundamental rating. CTEK was compared to 29 industry peers in the Energy Equipment & Services industry. While CTEK is still in line with the averages on profitability rating, there are concerns on its financial health. CTEK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CTEK was profitable.
In the past year CTEK had a positive cash flow from operations.
In the past 5 years CTEK reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CTEK reported negative operating cash flow in multiple years.
CTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFCTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.27%, CTEK is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
The Return On Equity of CTEK (73.37%) is better than 92.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.63%, CTEK is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
ROA 8.27%
ROE 73.37%
ROIC 11.63%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTEK.CA Yearly ROA, ROE, ROICCTEK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

CTEK's Profit Margin of 9.72% is amongst the best of the industry. CTEK outperforms 85.19% of its industry peers.
Looking at the Operating Margin, with a value of 13.90%, CTEK belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
CTEK has a better Gross Margin (60.26%) than 96.30% of its industry peers.
In the last couple of years the Gross Margin of CTEK has grown nicely.
Industry RankSector Rank
OM 13.9%
PM (TTM) 9.72%
GM 60.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y10.99%
CTEK.CA Yearly Profit, Operating, Gross MarginsCTEK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTEK is creating some value.
The number of shares outstanding for CTEK has been increased compared to 1 year ago.
CTEK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTEK has been reduced compared to a year ago.
CTEK.CA Yearly Shares OutstandingCTEK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M
CTEK.CA Yearly Total Debt VS Total AssetsCTEK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M

2.2 Solvency

CTEK has an Altman-Z score of -4.75. This is a bad value and indicates that CTEK is not financially healthy and even has some risk of bankruptcy.
CTEK's Altman-Z score of -4.75 is on the low side compared to the rest of the industry. CTEK is outperformed by 85.19% of its industry peers.
The Debt to FCF ratio of CTEK is 19.30, which is on the high side as it means it would take CTEK, 19.30 years of fcf income to pay off all of its debts.
CTEK has a worse Debt to FCF ratio (19.30) than 70.37% of its industry peers.
CTEK has a Debt/Equity ratio of 5.22. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.22, CTEK is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.22
Debt/FCF 19.3
Altman-Z -4.75
ROIC/WACC1.35
WACC8.62%
CTEK.CA Yearly LT Debt VS Equity VS FCFCTEK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

CTEK has a Current Ratio of 0.77. This is a bad value and indicates that CTEK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CTEK (0.77) is worse than 88.89% of its industry peers.
CTEK has a Quick Ratio of 0.77. This is a bad value and indicates that CTEK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CTEK (0.75) is worse than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.75
CTEK.CA Yearly Current Assets VS Current LiabilitesCTEK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

CTEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.14%, which is quite impressive.
CTEK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.74%.
The Revenue has been growing by 60.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-15.74%
Revenue growth 3Y10.15%
Revenue growth 5Y60.69%
Sales Q2Q%39.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTEK.CA Yearly Revenue VS EstimatesCTEK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CTEK.CA Yearly EPS VS EstimatesCTEK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -0.05 -0.1 -0.15

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.75, which indicates a rather expensive current valuation of CTEK.
CTEK's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.86, CTEK is valued at the same level.
Industry RankSector Rank
PE 23.75
Fwd PE N/A
CTEK.CA Price Earnings VS Forward Price EarningsCTEK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CTEK's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTEK indicates a slightly more expensive valuation: CTEK is more expensive than 62.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.43
EV/EBITDA 5.94
CTEK.CA Per share dataCTEK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The decent profitability rating of CTEK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTEK!.
Industry RankSector Rank
Dividend Yield N/A

CLEANTEK INDUSTRIES INC

TSX-V:CTEK (10/3/2025, 7:00:00 PM)

0.475

+0.02 (+5.56%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-25 2025-04-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.7%
Ins Owner ChangeN/A
Market Cap13.93M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.75
Fwd PE N/A
P/S 1.09
P/FCF 24.43
P/OCF 7.29
P/B 6.96
P/tB 7.96
EV/EBITDA 5.94
EPS(TTM)0.02
EY4.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY4.09%
OCF(TTM)0.07
OCFY13.71%
SpS0.44
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.27%
ROE 73.37%
ROCE 18.4%
ROIC 11.63%
ROICexc 12%
ROICexgc 12.29%
OM 13.9%
PM (TTM) 9.72%
GM 60.26%
FCFM 4.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y10.99%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 5.22
Debt/FCF 19.3
Debt/EBITDA 2.28
Cap/Depr 63.81%
Cap/Sales 10.5%
Interest Coverage 2.22
Cash Conversion 49.3%
Profit Quality 45.97%
Current Ratio 0.77
Quick Ratio 0.75
Altman-Z -4.75
F-Score7
WACC8.62%
ROIC/WACC1.35
Cap/Depr(3y)57.54%
Cap/Depr(5y)38.95%
Cap/Sales(3y)11.97%
Cap/Sales(5y)8.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.74%
Revenue growth 3Y10.15%
Revenue growth 5Y60.69%
Sales Q2Q%39.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y400.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.64%
OCF growth 3YN/A
OCF growth 5YN/A